Paasa Logo
Charmacy Pharmaceutical Co., Ltd. logo
2289HKSEMarket closedOpens 9:30am HKT

Charmacy Pharmaceutical Co., Ltd.

HK$5.50Last updated
-HK$0.01 (0.09%)Past day
Timezone
No price history for this range.

Charmacy Pharmaceutical Co., Ltd. (HKSE: 2289) is trading at HK$5.50, about ₹67 at today's HKD/INR rate, as of 9 Sep 2026, 6:07 AM ET, down 0.09% today. Indian residents can buy Charmacy Pharmaceutical from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:HK$5.50
Previous close:HK$5.50
Volume:500.00

Today's low

HK$5.50

Today's high

HK$5.50

52 week low

HK$4.30

52 week high

HK$7.40

2289 opened at HK$5.50, closed previously at HK$5.50, and has traded between HK$4.30 and HK$7.40 over the past 52 weeks.

About

Charmacy Pharmaceutical Co., Ltd. serves as a prominent distributor of pharmaceutical products across the People's Republic of China. The company's comprehensive portfolio includes Western medications, traditional Chinese patent medicines, and various healthcare items, along with associated advisory services. These are supplied to both wholesale distributors and retail pharmacies. Furthermore, Charmacy operates "Charmacy e-Medicine," its proprietary B2B digital platform, which enables clients to efficiently place orders, make inquiries, and process payments online. Founded in 1984, the firm maintains its headquarters in Shantou, PRC. It was formerly known as Chuangmei Pharmaceutical Co., Ltd. until its official renaming to Charmacy Pharmaceutical Co., Ltd. in July 2016.

Country
CN
CEO
Chuanglong Yao
Exchange listed on
HKSE
Industry
Medical - Distribution
Base currency
HKD
Full Time Employees
827
Sector
Healthcare
IPO date
14/12/2015

Key statistics

Avg. volume

614.00

Market cap

HK$593.46M

P/E Ratio

10.92

Price-to-sales ratio

0.11

Enterprise value

CN¥2.07B

Free cash flow yield

50.85%

Debt-to-equity ratio

3.45

Return on equity

7.70%

ROIC

2.58%

Beta

-0.96

Dividend yield

6.25%

Last dividend

HK$0.34

Financial overview

Revenue

CN¥4.38B

Earnings per share

CN¥0.43

Free cash flow

CN¥263.42M

Net profit margin

1.01%

Gross margin

7.24%

EBITDA

CN¥152.14M

Revenue growth

-1.15%

Similar securities

This is not an investment recommendation

How to buy Charmacy Pharmaceutical from India

Indian residents can buy Charmacy Pharmaceutical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.

  3. Search for Charmacy Pharmaceutical and place an order

    Find Charmacy Pharmaceutical by name or by its ticker, 2289, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Charmacy Pharmaceutical trades 7:00 am – 1:30 pm IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Charmacy Pharmaceutical position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.

Read the full guide: how to invest in Charmacy Pharmaceutical from India

Trading and taxes when buying Charmacy Pharmaceutical from India

Trading and limits

Trading hours
9:30 am – 4:00 pm HKT
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Charmacy Pharmaceutical’s current yield is 6.25%.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

FAQs

Can Indian residents buy Charmacy Pharmaceutical stock?

Yes. Charmacy Pharmaceutical (2289) has been listed on the Hong Kong Stock Exchange since 2015, in the Medical - Distribution industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.

How much does one Charmacy Pharmaceutical share cost in rupees?

One Charmacy Pharmaceutical share is HK$5.50 — about ₹67 at an HKD/INR rate of 12.25 on 28 Sep 2026. Both the Charmacy Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Charmacy Pharmaceutical from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

What is the minimum I can buy of Charmacy Pharmaceutical?

Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.

How are gains on Charmacy Pharmaceutical shares taxed in India?

Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Charmacy Pharmaceutical price. Paasa issues a capital-gains statement for your return.

Does Charmacy Pharmaceutical pay a dividend, and how is it taxed in India?

Yes. Charmacy Pharmaceutical pays a dividend and the current yield is 6.25%; the last declared dividend was HK$0.34 per share, about ₹4.21. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.

When can I trade Charmacy Pharmaceutical from India?

The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.

Is Charmacy Pharmaceutical a Hong Kong SAR China company, and does that change how it is taxed?

Charmacy Pharmaceutical trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Charmacy Pharmaceutical trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.

Do I have to declare Charmacy Pharmaceutical shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Charmacy Pharmaceutical holding, its cost and its closing value.

How do I sell Charmacy Pharmaceutical and bring the money back to India?

You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.